Page last updated: 2024-11-07

metaraminol and Infarct

metaraminol has been researched along with Infarct in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JASMIN, G1
BAJUSZ, E1
Nelson, SR1

Other Studies

2 other studies available for metaraminol and Infarct

ArticleYear
[PATHOGENIC STUDY OF CARDIAC, RENAL AND MUSCULAR LESIONS INDUCED IN THE RAT BY METHOXAMINE AND METARAMINOL].
    Revue canadienne de biologie, 1964, Volume: 23

    Topics: Adrenalectomy; Coronary Vessels; Histamine Release; Infarction; Ischemia; Kidney; Metaraminol; Metho

1964
Effect of drugs on experimental brain edema in mice.
    Journal of neurosurgery, 1974, Volume: 41, Issue:2

    Topics: Acetazolamide; Animals; Brain; Brain Edema; Cortisone; Dextrans; Disease Models, Animal; Hexamethoni

1974
chemdatabank.com